Andrew D. Hamilton
|
Andrew D. Hamilton FRS |
|
|---|---|
| 16th President of New York University | |
|
Assumed office 1 January 2016 |
|
| Preceded by | John Sexton |
|
Vice-Chancellor of the University of Oxford |
|
|
In office 1 October 2009 – 31 December 2015 |
|
| Preceded by | John Hood |
| Succeeded by | Louise Richardson |
| Provost of Yale University | |
|
In office 1 October 2004 – 1 October 2008 |
|
| Preceded by | Susan Hockfield |
| Succeeded by | Peter Salovey |
| Personal details | |
| Born |
Andrew David Hamilton 3 November 1952 |
| Spouse(s) | Jennifer |
| Children | Alastair, Claire and Malcolm |
| Residence | Greenwich Village, New York |
Andrew David Hamilton FRS (born 3 November 1952) is a British chemist and academic who is the 16th and current President of New York University. From 2009 to 2015, he served as the Vice-Chancellor of the University of Oxford. Before leading Oxford, he was Provost of Yale University from 2004 to 2008.
Andrew Hamilton was a pupil at the Royal Grammar School, Guildford. He studied chemistry at the University of Exeter, graduating with a first class Bachelor of Science (BSc) degree. After studying for a master’s degree at the University of British Columbia, he received his Ph.D. degree from St John's College, Cambridge in 1980 with a thesis titled "Models for oxygen-binding hemoproteins" under the supervision of Alan R. Battersby and then spent a post-doctoral period at the Université Louis Pasteur in Strasbourg. He received honorary doctorates from the University of Surrey, Tsinghua University, and the University of Exeter, among others.
In 1981, he was appointed Assistant Professor of Chemistry at Princeton University then in 1988 as Professor of Chemistry at the University of Pittsburgh. In 1997 he moved to Yale as Benjamin Silliman Professor of Chemistry and Professor of Molecular Biophysics and Biochemistry at Yale University. Hamilton's research has spanned porphyrin, supramolecular, medicinal, bioorganic chemistry and chemical biology. His laboratory is most noted for the design of barbiturate hosts, farnesyl tranferase inhibitors, protein surface binders, and helix mimetics. In 2004 he was elected a Fellow of the Royal Society.
...
Wikipedia